InvestorsHub Logo
Followers 200
Posts 10576
Boards Moderated 0
Alias Born 11/29/2011

Re: None

Sunday, 03/29/2015 12:05:57 PM

Sunday, March 29, 2015 12:05:57 PM

Post# of 92702
$RIGH. Clean Balance Sheet. No Long-Term Debt. wink
...major #Bud Genius, Inc. pending news.

http://angelstanz.com/

http://bgmedtech.com

http://budgenius.com

$RIGH 3rd Quarter Filing Indicate Business Doubled QoQ.

http://www.otcmarkets.com/otciq/ajax/showFinancialReportById.pdf?id=129668

Which matches the PR in September.
http://bgmedtech.com/bud-genius-doubles-scope-of-business/

More Than Half FY-to-Date Revs, Earned in Q3 indicated in Fins:


Net Losses Thru 9 Months Ending, Sep 30, 2014 - just $68K:




Cash and Cash Equivalents Outweigh to date Losses:




$55K of net losses were Depreciation (a tax write off):



Total Equity/Paid In Capital, clears ALL losses - positive $1.183 million.



It's noted in the financials first in FYE13, which is backed up again in the most-recent Q3E/2014.
“The company currently has no long-term commitments as of our balance sheet date.”




Business more than doubled in Q3, with a 33%+ increase QoQ in strain testing in Q4 (over and above Q3).

#BudGenius Business Significantly Increasing QoQ...

65 strain analysis reports in Q4/2014 (to date).


http://budgenius.com/search.html?cmd=search&more=2&search_type=1&Thc9_max=30&Cbd_max=10&Cbn_max=10&radius=10&tab=2&p=0&pp=500

49 strain analysis reports in Q3/2014.

http://budgenius.com/search.html?cmd=search&more=2&search_type=1&Thc9_max=30&Cbd_max=10&Cbn_max=10&radius=10&tab=2&p=0&pp=500

And the lab isn't the only place RIGH derives its income from.




Beyond the clean balance sheet (indicated above), financing doesn't
seem to be a problem either...




Access to financing matches the company PR outlined in August.
Bud Genius Receives Funding Commitment from Angel Investor
Aug 21, 2014

OTC Disclosure & News Service

http://www.otcmarkets.com/stock/RIGH/news/Bud-Genius-Receives-Funding-Commitment-from-Angel-Investor?id=86569&b=y

Financing in Q4/2013, reopens doors to product development.



A new "Roadmap to Success" a.k.a. "modified release schedule"
was delivered earlier this month by the company.


http://bgmedtech.com/bud-genius-issues-2015-roadmap-to-success/